133 related articles for article (PubMed ID: 35025806)
21. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK
Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
[TBL] [Abstract][Full Text] [Related]
22. False-positive radioiodine uptake in a functional ovarian cyst in a patient treated with total thyroidectomy for papillary cancer.
Jang HY; Kim BH; Kim WJ; Jeon YK; Kim SS; Kim YK; Kim IJ
Intern Med; 2013; 52(20):2321-3. PubMed ID: 24126393
[TBL] [Abstract][Full Text] [Related]
23. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
Koh JM; Kim ES; Ryu JS; Hong SJ; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
[TBL] [Abstract][Full Text] [Related]
24. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
25. 131I uptake in intraosseous hemangioma of the skull: mimicking a bone metastasis in thyroid cancer.
Lee M; Lee YK; Jeon TJ; Park CS; Ryu YH
Clin Nucl Med; 2014 Nov; 39(11):990-2. PubMed ID: 24978336
[TBL] [Abstract][Full Text] [Related]
26. False-positive 131I uptake by the temporomandibular joint effusion.
Zhang M; Zhang Y; Huang W; Li B
Clin Nucl Med; 2013 Oct; 38(10):823-5. PubMed ID: 24107815
[TBL] [Abstract][Full Text] [Related]
27. False-Positive Radioiodine Uptake From an Intracranial Surgical Clip.
Walsh JP; Sims JB; Iranpour P
Clin Nucl Med; 2022 Mar; 47(3):e279-e280. PubMed ID: 35025781
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.
Dadparvar S; Chevres A; Tulchinsky M; Krishna-Badrinath L; Khan AS; Slizofski WJ
Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487
[TBL] [Abstract][Full Text] [Related]
29. Unexpectedly expected fetal thyroid function on posttreated radioiodine (131I) SPECT/CT of a patient with differentiated thyroid cancer.
Chamroonrat W; Sritara C; Utamakul C; Kositwattanarerk A; Thamnirat K; Anongpornjossakul Y
Clin Nucl Med; 2014 Nov; 39(11):1017-8. PubMed ID: 25036017
[TBL] [Abstract][Full Text] [Related]
30. Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
Yamazaki CA; Padovani RP; Biscolla RP; Ikejiri ES; Marchetti RR; Castiglioni ML; Matsumura LK; Maciel RM; Furlanetto RP
Thyroid; 2012 Oct; 22(10):1002-6. PubMed ID: 22953991
[TBL] [Abstract][Full Text] [Related]
31. Association between residual thyroid carcinoma and diffuse hepatic uptake of 131I following radioiodine ablation in postoperative total thyroidectomy patients.
Tatar FA; Morita E; Ituarte PH; Cavalieri RR; Duh QY; Price DC; Siperstein AE; Clark OH
World J Surg; 2001 Jun; 25(6):718-22. PubMed ID: 11376405
[TBL] [Abstract][Full Text] [Related]
32. Multifocal hot spots demonstrated by whole-body 131I scintigraphy and SPECT/CT after transaxillary endoscopic thyroidectomy.
Kim HS; Kim SH; Kim JH; Kim BT; Lee KH
Clin Nucl Med; 2015 Mar; 40(3):260-2. PubMed ID: 25642914
[TBL] [Abstract][Full Text] [Related]
33. Radioactive Iodine for Papillary Thyroid Carcinoma.
Chan WWL; Kwong DLW
Methods Mol Biol; 2022; 2534():225-241. PubMed ID: 35670979
[TBL] [Abstract][Full Text] [Related]
34. Diffuse 131I lung uptake in bronchiectasis: a potential pitfall in the follow-up of differentiated thyroid carcinoma.
Triggiani V; Moschetta M; Giagulli VA; Licchelli B; Guastamacchia E
Thyroid; 2012 Dec; 22(12):1287-90. PubMed ID: 23067330
[TBL] [Abstract][Full Text] [Related]
35. 131I Whole-Body Scan Incidental Uptake Due to Spermatocele.
Albano D; Motta F; Baronchelli C; Lucchini S; Bertagna F
Clin Nucl Med; 2017 Nov; 42(11):901-904. PubMed ID: 28902733
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer.
Shankar LK; Yamamoto AJ; Alavi A; Mandel SJ
J Nucl Med; 2002 Jan; 43(1):72-6. PubMed ID: 11801706
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
38. Impact factors for the outcome of the first
Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
[TBL] [Abstract][Full Text] [Related]
39. Spurious metastasis on whole body scans in a patient with thyroid carcinoma.
Bajramovic S; DeGroot LJ
J Endocrinol Invest; 1998 Sep; 21(8):541-3. PubMed ID: 9801997
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]